Myrtenal and β-caryophyllene oxide screened from Liquidambaris Fructus suppress NLRP3 inflammasome components in rheumatoid arthritis
β-Caryophyllene oxide
Male
Polycyclic Sesquiterpenes
0301 basic medicine
Inflammasomes
Research
Rats, Inbred WF
Network Pharmacology
NLRP3 inflammasome
Rats
3. Good health
Arthritis, Rheumatoid
Molecular Docking Simulation
Other systems of medicine
03 medical and health sciences
Myrtenal
NLR Family, Pyrin Domain-Containing 3 Protein
Animals
Rheumatoid arthritis
Liquidambaris Fructus
RZ201-999
Bicyclic Monoterpenes
DOI:
10.1186/s12906-021-03410-2
Publication Date:
2021-09-28T14:02:50Z
AUTHORS (7)
ABSTRACT
Abstract Background Liquidambaris Fructus (LF) is the infructescence of Liquidambar formosana . In Traditional Chinese Medicine, LF has been used to treat joint pain, a common symptom arthritis and rheumatism; however, lack pharmacological evidence limited its applications in modern clinics. Therefore, this study aims explore protective effect on rheumatoid (RA) identify active ingredients. Methods Rats with adjuvant-induced (AIA) were divided into 4 groups administered petroleum ether extract (PEL), ethyl acetate (EEL), water (WEL), or piroxicam (PIR) respectively for 3 weeks. Two additional as normal control (NC) model (MC) distilled placebo. The clinical scores arthritis, bone surface, synovial inflammation cartilage erosion evaluate therapeutic efficacy each treatment. serum IL-1β TNF-α level expression NLRP3, caspase-1 p20 tissue AIA rats evaluated by ELISA Western blot. ingredients investigated using network pharmacology molecular docking methods, their inhibition NLRP3 inflammasome activation was verified human fibroblast-like cells (RA-FLS) model. Results PEL could alleviate paw swelling, destruction, rats, significantly superior that EEL WEL. reduced levels, attenuated upregulation rats. Network results indicated myrtenal β-caryophyllene oxide main two PEL, these compounds showed significant TNF-α, RA-FLS. Conclusions Myrtenal screened from suppress inflammasome, thereby alleviating RA symptoms.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (50)
CITATIONS (20)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....